BioAtla (BCAB) Return on Sales [ROS] (2020 - 2026)
BioAtla (BCAB) posted Return on Sales [ROS] of 3.49% for Q2 2026, up 583.27 percentage points from -579.77% a year earlier.
Powered by 
Analysis
BioAtla (BCAB) Return on Sales [ROS] (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Return on Sales [ROS] at BioAtla was -377.94%, up 201.83 percentage points year-over-year; for FY2025, it came in at -2965.25%, down 2293.04 percentage points from FY2024.
- Annual Return on Sales [ROS] shows a five-year change of +4050.83 percentage points (FY2020 to FY2025).
- In prior years, BioAtla's Return on Sales [ROS] was -672.21% in FY2024 and -38576.00% in FY2021 (-31559.92 pp).
- The Q2 2026 figure stands as the highest quarterly Return on Sales [ROS] in data going back to Q1 2020.
- On a year-over-year basis, Return on Sales [ROS] increased in three of the last four quarters, with an average year-over-year change of +13018.61 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 28.37% |
| 10 | BioAtla | 2.16 Mn | 2.16 Mn | - | 3.49% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.49% |
| Dec 31, 2025 | -462.75% |
| Sep 30, 2025 | -602.67% |
| Jun 30, 2025 | -579.77% |
| Dec 31, 2024 | -672.21% |
| Sep 30, 2024 | -102.45% |
| Sep 30, 2023 | -51,884.40% |
| Dec 31, 2021 | -38,576.00% |
| Sep 30, 2021 | -35,762.80% |
| Jun 30, 2021 | -12,184.00% |
| Mar 31, 2021 | -14,055.00% |
| Dec 31, 2020 | -7,016.08% |
| Sep 30, 2020 | -5,343.33% |
| Jun 30, 2020 | -2,378.95% |
| Mar 31, 2020 | -1,246.07% |
API Access
BioAtla Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=BCAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "BCAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=BCAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();